the cancer-specific mortality rate. From variation within and between monozygotic and dizygotic twin pairs born under …

involved. It has been argued that cancer should be considered a "dread disease", which supports the use of a "cancer premium …". The objective of this study is to elicit the existence and size of a cancer premium (for pancreatic cancer and multiple …-76 %) for cancer was found in relation to road traffic accidents, but not in relation to ALS and sudden cardiac arrest. The …

. The objective of this study is to elicit the existence and size of an EoL premium in cancer. Data was collected from 509 …. The value of a QALY at EoL in cancer was between €275,000 and €440,000, which is higher than the thresholds applied by … showed scale sensitivity. Thus this study supports an EoL premium in cancer when expected remaining lifetime is short. …

-outcome relationship on a regional (county or cancer registry) level. Using data from the National Cancer Institute's Surveillance …, Epidemiology and End Results program we find that regions with relatively more of the same cancer type exhibit relatively better …